25 Jun Atomo Diagnostics’ AtomoRapid™ blood test device selected as finalist at Medical Design Excellence Awards 2014
New York, June 10, 2014 |Atomo Diagnostics’ multi-award winning AtomoRapid™ HIV has been selected as a finalist in the In Vitro Diagnostic Products and Systems Category at the 17th Medical Design Excellence Awards (MDEA), held in New York this week. The winners will be announced at an awards ceremony tomorrow night in New York.
The MDEA is the medtech industry’s premier design competition committed to searching worldwide for the highest caliber finished medical devices, products, systems, or packaging available on the market.
The AtomoRapid™ blood testing platform can accommodate test strips for a wide variety of conditions from celiac disease, allergy through to infectious diseases such as malaria and HIV.
The device delivers better clinical outcomes for patients and health care providers by enabling simpler, safer and more accurate testing in the field or at home. (See product images here http://atomodiagnostics.com/latest-news/gallery/)
Atomo Diagnostics Founder & CEO John Kelly said: “Our company is delighted to be recognised for its work in developing AtomoRapid™, a revolutionary rapid diagnostic testing platform, and we would like to thank MDEA for selecting us as finalists in these prestigious awards, and our design partner, IDE for its excellent work in helping to bring this technology to market.
Given its ease of use and simplicity, AtomoRapid™ HIV has the ability to materially improve both the uptake and reliability of HIV testing in the community and at home and we are committed to getting the product launched in the US and Europe. AtomoRapid™ HIV is currently available for sale in several African countries from our South Africa office.
One of the 12 industry leader MDEA 214 judges George L. Walls, director of product and market development for ZOLL, said of AtomoRapid™:
“The AtomoRapid™ HIV hits on all cylinders: a real problem creatively and disruptively addressed. Fast, low cost, accurate, and fundamentally changing the use and business model in this important space. It’s EPT for HIV. ”
The awards program celebrates the achievements of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives; improving patient healthcare; and transforming medtech—one innovation at a time
“Clinical performance of standard test kits are proven in the lab, but serious concerns have been raised about in-field performance. This is down to their complex nature, requiring multiple components for the procedure offering resulting in errors, which in turn creates false diagnosis. For a disease such as HIV, this can have significant impact not only on the individual, but the community too,” said John Kelly.
The 12 member industry leader judging panel includes:
Tor Alden is principal of HS Design, a product development firm specializing in the medical and healthcare marketplace. Alden has expertise in new product development, design research, strategy, project management, and new business development. During his more than 20 years in product design and development, Alden has received more than 30 patents and several design awards, including MDEA, IDEA, CES Innovations, and Good Design honors.
Yadin B. David is the founder of Biomedical Engineering Consultants LLC, a Houston firm that provides assessment of medical technology management operations, regulatory compliance, and forensic engineering services for hospitals and industry worldwide. For 25 years, David headed the biomedical engineering department and the Center for Telehealth at Texas Children’s Hospital in Houston.
Ross Donaldson, MD, MPH, CTropMed, FACEP, is director of the Emergency Medicine Global Health Program at Harbor-UCLA Medical Center and holds appointments in the UCLA Schools of Medicine and Public Health. Featured on CNN, BBC, NPR, and other media outlets, he is the critically acclaimed author of The Lassa Ward, a memoir about international humanitarian work, and the creator of WikEM, a smartphone application for emergency clinicians.
Craig M. Jackson, PhD, operates a San Diego–based consulting practice and serves as the program director for The Hartwell Foundation, a foundation supporting innovative, high-risk research related to diseases in children. He has written more than 75 original papers, contributed to more than 30 textbooks, writes regularly for both professional and trade journals, and holds several patents.
Raj Khandwalla, MD, MA, FACC, is a board-certified cardiologist practicing with the Cedars-Sinai Medical Group (CSMG) and Cedars-Sinai Heart Institute. In addition, he is codirector of the CSMG Heart Failure Program, which has pioneered the use of biomarkers and handheld ultrasound to optimize therapy and reduce hospital re-admission rates.
Stephanie Kreml is a principle at Popper and Co., were she develops and implements business strategy for startup companies and new business units in existing companies. She consults in the areas of clinical need, commercialization, and technology assessment; performs due diligence for investment and acquisition targets in the life science industry; evaluates unmet clinical needs and technologies; and provides guidance to accelerate new product development.
Jonathan Y. Lee, MD, ABEM, is the quality improvement director at Scripps Mercy Hospital, a tertiary care, level-one trauma center in San Diego. He has also served as the chairperson of the Emergency Medicine Department and education director. Lee has volunteered for numerous disasters and charities including International Relief Team, International Latin American Concerns, Scripps Medical Relief Team, and Disaster Medical Relief Team.
Pascal Malassigné, FIDSA, is the senior professor and chair of industrial design at the Milwaukee Institute of Art and Design. He is a career research scientist and industrial designer at the Milwaukee Veterans Affairs Medical Center and an adjunct assistant professor of rehabilitation at the Medical College of Wisconsin. He is among the foremost designers of assistive and wheeled mobility devices.
Richard Meyst is president and CEO of Fallbrook Engineering Inc., an Escondido, CA-based contract product design, development, management, and engineering services consulting firm specializing in healthcare products. He is also president and CEO of Cellection Systems, a startup company commercializing a cord blood collection product for cellular therapy.
Mary Beth Privitera is the director of the University of Cincinnati Medical Center’s Medical Device Engine, a design team aimed at optimizing medical device design. She holds a joint appointment as
associate professor with the University of Cincinnati’s College of Medicine and College of Engineering and Applied Science. For the past nine years, she has also been the codirector of the university’s Medical Device Innovation and Entrepreneurship program.
Mark S. Vreeke, PhD, is a cofounder of the Chemical Angel Network, which brings together entrepreneurs and investors who are working on growing companies with a strong chemistry component. His specialties are in the broad areas of medical devices and diagnostics, information technology, and energy transportation. Vreeke is also a founding partner at enterprise software firm Rational Systems and has worked at several medical device and diagnostic firms.
George L. Walls is the director of product and market development for ZOLL, an Asahi Kasei Group company. For more than 25 years he has led innovation teams across multiple disciplines to develop, launch, and market advanced technology and medical devices. Walls previously worked for St. Jude Medical and Laerdal Medical Corp and holds several patents.
About Atomo Diagnostics www.atomodiagnostics.com
Atomo Diagnostics is an award-winning Australian based healthcare company with a focus on product development and usability. Atomo develops and commercialises next generation solutions that address unmet user needs in the diagnostic industry.
AtomoRapid™ Malaria, the second test to market, will be available in the 3rd Quarter of 2014 and we plan to introduce additional tests in the coming 18 months.
The company is actively seeking partners for market entry into the US and Europe.
About the MDEA Program
The Medical Design Excellence Awards are presented by UBM Canon, the global advanced manufacturing and medtech authority, and by Medical Device and Diagnostic Industry (MD+DI), the industry’s central source for late breaking news, information, and business intelligence.The 2014 Medical Design Excellence Awards are sponsored by: K-Tube Technologies; Medical Packaging Community; Phillips-Medisize; Proto Labs; Stellar Technologies; and Teleflex Medical OEM.
Entries are judged by an impartial panel of medtech experts. Unlike other design competitions that are merely styling contests, the MDEA jury is comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts. MDEA jurors comprehensively review entries based on the following criteria: the ability of the product development team to overcome all challenges so the product meets its clinical objectives; innovative use of materials, components, and processes; user-related functions improving healthcare delivery and changing traditional medical attitudes or practices; features providing enhanced benefits to the patient and end-user in relation to clinical efficacy; manufacturing cost-effectiveness and profitability; and healthcare system benefits such as improved accessibility, efficacy, or safety, in addition to providing attention to a critical unmet clinical need.
For more info e-mail email@example.com.